|
2023
|
Invention
|
Methods of reducing physical dependence to neuropsychiatric treatments. Neuropsychiatric treatmen... |
|
|
Invention
|
Ulotaront for the adjuvant treatment of major depressive disorder. Provided are antidepressant th... |
|
|
Invention
|
Methods of treating social function disorders.
Methods and compositions for treating social func... |
|
|
Invention
|
Modified release formulations and uses thereof. Provided are modified release compositions in a s... |
|
2022
|
Invention
|
Nonracemic mixtures and uses thereof. Provided are compositions comprising unequal mixtures of (R... |
|
|
Invention
|
Methods of treating metabolic disorders.
Provided herein are compounds, pharmaceutical compositi... |
|
|
Invention
|
Methods of treating metabolic disorders. Provided herein are compounds, pharmaceutical compositio... |
|
|
Invention
|
Methods for preparing crystalline forms of amisulpride.
Provided are methods for making crystall... |
|
|
Invention
|
Methods for preparing crystalline forms of amisulpride. Provided are methods for making crystalli... |
|
|
Invention
|
Crystal forms and production methods thereof. The various aspects present inventions provide vari... |
|
|
Invention
|
Taar1 and serotonin modulators, and pharmaceutical compositions, and methods of use thereof.
Pro... |
|
|
Invention
|
Taar1 and serotonin modulators, and pharmaceutical compositions, and methods of use thereof. Prov... |
|
|
Invention
|
Isochroman derivatives and compositions and uses thereof.
Disclosed are isochromane and related ... |
|
|
Invention
|
Isochroman derivatives and compositions and uses thereof. Disclosed are isochromane and related c... |
|
|
Invention
|
Substituted sulfonamide-chroman compounds, and pharmaceutical compositions, and methods of use th... |
|
|
Invention
|
Chromans and benzofurans as 5-ht1a and taar1 agonists.
Provided herein are compounds, pharmaceut... |
|
|
Invention
|
Chromans and benzofurans as 5-ht1a and taar1 agonists. e.g.e.g., Ring A, X1, R1, R2, R3, R4, and ... |
|
|
Invention
|
Fused dihydro-4h-pyrazolo[5,1-c][1,4]oxazinyl compounds and analogs for treating cns disorders. D... |
|
|
Invention
|
Computational model and methods for selecting clinical trial subjects to reduce heterogeneity.
C... |
|
|
Invention
|
Computational model and methods for selecting clinical trial subjects to reduce heterogeneity. Cl... |
|
|
Invention
|
Multicyclic compounds and methods of use thereof.
Provided herein are multicyclic compounds, met... |
|
2021
|
Invention
|
Salts of a heterocyclic compound and crystalline forms, processes for preparing, therapeutic uses... |
|
|
Invention
|
Methods of treating a patient having parkinson's disease.
Methods of treating a patient having P... |
|
|
G/S
|
Pharmaceutical preparations for treating central nervous system diseases or disorders; pharmaceut... |
|
|
Invention
|
(s)-(4,5-dihydro-7h-thieno[2,3-c]pyran-7-yl)-n-methylmethanamine for treating neurological and ps... |
|
|
Invention
|
Methods of treating neurological and psychiatric disorders. The present disclosure relates to met... |
|
|
Invention
|
Methods of treating schizophrenia.
Provided herein are methods for determining if a compound has... |
|
|
Invention
|
Sublingual apomorphine.
The invention features sublingual formulations of apomorphine and apomor... |
|
|
Invention
|
Methods of treating parkinson's disease by administration of apomorphine to an oral mucosa.
Meth... |
|
2020
|
Invention
|
Easy-open peel pouch. Embodiments include a package for containing and dispensing a product. The ... |
|
|
Invention
|
Salts, crystal forms, and production methods thereof. Provided are salts of (S)-(4,5-dihydro-7H-t... |
|
|
Invention
|
Child-resistant dispensers for thin strip medications.
Product containers, especially child-resi... |
|
|
Invention
|
Child-resistant dispensers for thin strip medications. Product containers, especially child-resis... |
|
|
Invention
|
Modified release formulations and uses thereof.
Provided are modified release compositions in a ... |
|
|
Invention
|
Treatment of cns disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine... |
|
|
Invention
|
Child resistant peel pouch.
Disclosed are packages for dispensing a product, the package includi... |
|
2019
|
Invention
|
Methods of treating central nervous system disorders.
Provided herein are methods of treating ce... |
|
|
G/S
|
Pharmaceutical preparations for treating central nervous system diseases or disorders, namely, ce... |
|
|
Invention
|
Nebulizer monitoring device, system and method cross-reference to related application. Described ... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of Parkinson's disease and Parkinson's disease off ... |
|
|
Invention
|
Oral dosage forms.
The present application generally relates to pharmaceutical compositions comp... |
|
2018
|
G/S
|
Pharmaceutical preparations for treating central nervous system diseases and disorders, namely, c... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of Parkinson's Disease; pharmaceutical preparations... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of Parkinson's
disease; pharmaceutical preparation... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of the diseases, disorders and infections of the ce... |
|
|
G/S
|
Printed materials, namely, booklets, brochures, leaflets, newsletters, articles, pamphlets and re... |
|
|
G/S
|
Printed materials, namely, booklets, brochures, hand-outs,
leaflets, newsletters, articles, pamp... |
|
|
G/S
|
Printed materials, namely, booklets, brochures, leaflets, newsletters, articles, pamphlets, repor... |
|
|
G/S
|
Printed materials, namely, booklets, brochures, hand-outs, leaflets and pamphlets, in the field o... |
|
2017
|
G/S
|
providing health information in the field of educational information about health and disease awa... |
|
|
G/S
|
Printed materials, namely, booklets, brochures, hand-outs, leaflets, newsletters, articles, pamph... |
|
|
G/S
|
Downloadable electronic publications in the nature of rating scales for scientific, clinical and ... |
|
|
G/S
|
Providing educational health information in the field of health and disease awareness, prevention... |
|
|
G/S
|
Pharmaceutical preparations for use in respiratory therapy and for the treatment of lung, nasal a... |
|
|
G/S
|
Pharmaceutical preparations for use in respiratory therapy
and for the treatment of lung, nasal ... |
|
2016
|
G/S
|
Sublingual thin filmstrip of apomorphine to treat Parkinson's Disease OFF (hypomobility) episodes... |
|
|
G/S
|
Pharmaceutical preparations for treating central nervous system diseases or disorders. |
|
|
G/S
|
Pharmaceutical preparations for the treatment of central nervous system disorders, namely, centra... |
|
|
G/S
|
Providing educational information in the field of health and disease awareness, prevention and tr... |
